Meghna Talekar

1.6k citations
23 papers · 1.2k indexed · h-index 21
Topics
Nanoparticle-Based Drug Delivery (7 papers)Nanoplatforms for cancer theranostics (4 papers)Cancer Research and Treatments (3 papers)

In The Last Decade

Meghna Talekar

23 papers receiving 1.2k citations

Peers

Meghna Talekar
Comparison fields: 5 of 117
  • Molecular Biology 543
  • Biomaterials 335
  • Biomedical Engineering 255
  • Immunology 231
  • Cancer Research 196
Replace Raúl Ortíz with:
Raúl Ortíz Spain
Huimin Yao China
Jacinta O. Pinho Portugal
Paras Famta India
Sohee Son South Korea
Derek J. Quinn United Kingdom
Imran Vhora India
Mara C. Ebeling United States
Sushilkumar Patil India
Meghna Talekar relative to Raúl Ortíz Spain Raúl Ortíz's profile →
Citations per field
00.5×1.5×2.1×
Raúl Ortíz · 1×
Citations per year

Countries citing papers authored by Meghna Talekar

Since Specialization
Citations

This map shows the geographic impact of Meghna Talekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghna Talekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghna Talekar more than expected).

Fields of papers citing papers by Meghna Talekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghna Talekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghna Talekar. The network helps show where Meghna Talekar may publish in the future.

Co-authorship network of co-authors of Meghna Talekar

This figure shows the co-authorship network connecting the top 25 collaborators of Meghna Talekar. A scholar is included among the top collaborators of Meghna Talekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghna Talekar. Meghna Talekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 102
3 74
4 37
5 78
6 44
7 48
8 35
9 31
10 127
11 36
12 62
13 165
14 9
15 46
16 27
17 22
18 30
19 85
20 31

About Meghna Talekar

Meghna Talekar is a scholar working on Pharmaceutical Science, Biomaterials and Applied Microbiology and Biotechnology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Pharmaceutical Science (182 citations), Biomaterials (335 citations) and Applied Microbiology and Biotechnology (28 citations). Meghna Talekar has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Mansoor M. Amiji, Amit Singh, Sanjay Garg, Srinivas Ganta, Malav Trivedi, Amit Singh, William A. Denny, Jackie D. Kendall, Timothy P. Coleman and Parin Shah. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026